Insights

Strategic Acquisition JOTEC's acquisition by CryoLife for $225 million indicates strong backing and integration into a larger medical device ecosystem, presenting opportunities to leverage CryoLife’s wider distribution channels to expand JOTEC’s market reach.

Niche Product Portfolio Specializing in advanced aortic, peripheral vascular devices, and mechanical heart valves positions JOTEC as a key provider for hospital systems seeking innovative cardiovascular solutions, suggesting potential to upsell or cross-sell related products in high-value clinical settings.

Emerging Market Presence With a relatively modest revenue base and a focus on innovative surgical solutions, JOTEC offers growth potential through targeting hospital procurement managers and cardiovascular specialists seeking cutting-edge minimally invasive technologies.

Innovation Focus Continuous development and clinician partnerships highlight JOTEC’s commitment to innovation, providing sales opportunities by introducing new technologically advanced products to clinicians eager for improved treatment outcomes.

Industry Positioning Operating within a competitive landscape alongside companies like Cook Medical and Terumo Aortic, JOTEC can be positioned as a specialized provider for hospitals focused on expanding cardiovascular treatment options, offering targeted messaging for strategic partnerships and tenders.

Similar companies to JOTEC GmbH a fully owned subsidiary of CryoLife, Inc.

JOTEC GmbH a fully owned subsidiary of CryoLife, Inc. Tech Stack

JOTEC GmbH a fully owned subsidiary of CryoLife, Inc. uses 8 technology products and services including jQuery CDN, Cookiebot, Google Fonts API, and more. Explore JOTEC GmbH a fully owned subsidiary of CryoLife, Inc.'s tech stack below.

jQuery CDN
Content Delivery Network
Cookiebot
Cookie Compliance
Google Fonts API
Font Scripts
yepnope.js
Javascript Frameworks
jQuery
Javascript Libraries
Modernizr
Javascript Libraries
Google Analytics
Web Analytics
Apache HTTP Server
Web Servers

Media & News

CryoLife, Inc. acquired Jotec for $225M on Oct 1st '17.
CryoLife has announced the completion of its takeover of the medical technology firm Jotec, a deal worth an initial $225 million (168.09 million pounds).
Dec 05, 2017 | www.zenopa.com

JOTEC GmbH a fully owned subsidiary of CryoLife, Inc.'s Email Address Formats

JOTEC GmbH a fully owned subsidiary of CryoLife, Inc. uses at least 2 format(s):

JOTEC GmbH a fully owned subsidiary of CryoLife, Inc. Email Formats	Example	Percentage
Last.First@cryolife.com	Doe.John@cryolife.com	78%
First.Last@cryolife.com	John.Doe@cryolife.com	7%
LastFirst@cryolife.com	DoeJohn@cryolife.com	2%
First-Last@cryolife.com	John-Doe@cryolife.com	1%
First_Last@cryolife.com	John_Doe@cryolife.com	1%
FirLast@cryolife.com	JohDoe@cryolife.com	1%
FirstLast@cryolife.com	JohnDoe@cryolife.com	1%
L.First@cryolife.com	D.John@cryolife.com	1%
LastFir@cryolife.com	DoeJoh@cryolife.com	1%
LastF@cryolife.com	DoeJ@cryolife.com	1%
Last_First@cryolife.com	Doe_John@cryolife.com	1%
FirstLas@cryolife.com	JohnDoe@cryolife.com	1%
Last.F@cryolife.com	Doe.J@cryolife.com	1%
LFirst@cryolife.com	DJohn@cryolife.com	1%
FirstMLa@cryolife.com	JohnMDo@cryolife.com	1%
Middle@cryolife.com	Michael@cryolife.com	1%
First.Last@jotec.com	John.Doe@jotec.com	83%
First.L@jotec.com	John.D@jotec.com	7%
L.First@jotec.com	D.John@jotec.com	6%
FirstLas@jotec.com	JohnDoe@jotec.com	4%

Frequently Asked Questions

Where is JOTEC GmbH a fully owned subsidiary of CryoLife, Inc.'s headquarters located?

JOTEC GmbH a fully owned subsidiary of CryoLife, Inc.'s main headquarters is located at Lotzenäcker 23 Hechingen, Baden-Württemberg 72379 DE. The company has employees across 4 continents, including EuropeNorth AmericaSouth America.

What is JOTEC GmbH a fully owned subsidiary of CryoLife, Inc.'s official website and social media links?

JOTEC GmbH a fully owned subsidiary of CryoLife, Inc.'s official website is jotec.com and has social profiles on LinkedIn.

What is JOTEC GmbH a fully owned subsidiary of CryoLife, Inc.'s NAICS code?

JOTEC GmbH a fully owned subsidiary of CryoLife, Inc.'s NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does JOTEC GmbH a fully owned subsidiary of CryoLife, Inc. have currently?

As of October 2021, JOTEC GmbH a fully owned subsidiary of CryoLife, Inc. has approximately 1K employees across 4 continents, including EuropeNorth AmericaSouth America. Key team members include Chief People Officer: B. E.President & Chief Executive Officer: P. M.Company Director: D. L.. Explore JOTEC GmbH a fully owned subsidiary of CryoLife, Inc.'s employee directory with LeadIQ.

What industry does JOTEC GmbH a fully owned subsidiary of CryoLife, Inc. belong to?

JOTEC GmbH a fully owned subsidiary of CryoLife, Inc. operates in the Medical Equipment Manufacturing industry.

What technology does JOTEC GmbH a fully owned subsidiary of CryoLife, Inc. use?

JOTEC GmbH a fully owned subsidiary of CryoLife, Inc.'s tech stack includes jQuery CDNCookiebotGoogle Fonts APIyepnope.jsjQueryModernizrGoogle AnalyticsApache HTTP Server.

What is JOTEC GmbH a fully owned subsidiary of CryoLife, Inc.'s email format?

JOTEC GmbH a fully owned subsidiary of CryoLife, Inc.'s email format typically follows the pattern of Last.First@cryolife.com. Find more JOTEC GmbH a fully owned subsidiary of CryoLife, Inc. email formats with LeadIQ.

When was JOTEC GmbH a fully owned subsidiary of CryoLife, Inc. founded?

JOTEC GmbH a fully owned subsidiary of CryoLife, Inc. was founded in 2000.

JOTEC GmbH a fully owned subsidiary of CryoLife, Inc.

Medical Equipment ManufacturingBaden-Württemberg, Germany1001-5000 Employees

We develop, manufacture and market medical devices for aortic and peripheral vascular disease aswell as mechanical heart valves, surgigal adhesive, mitral chordal replacement products and a polysaccharide hemostatic system.
 Our product portfolio includes conventional grafts, interventional implants and heart valves for cardiovascular
 surgery, radiology and cardiology. 

 We aspire to offer the best solutions for both, patients and physicians, and target this vision through continuous innovation and development. We partner with clinicians to restore health by delivering innovative technologies.